Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase IV registration trial.

Jasper VergutsPierre Arnaud GodinBart De VreeOlivier DonnezStefan CosynsMathieu LuyckxMichelle Nisolle

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2019)

By administering UPA, the required rate of surgery was significantly decreased. Also, the resulting reduction in size of the fibroids could have the potential benefit of reducing surgery-related complications, and long-term use may be warranted to avoid surgery completely.

Keyphrases

minimally invasive
coronary artery bypass
surgical site infection
clinical trial
randomized controlled trial
study protocol
coronary artery disease
percutaneous coronary intervention
risk assessment
pregnant women
phase iii
human health
acute coronary syndrome
atrial fibrillation
double blind